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ABSTRACT A molecular model of the low-pH-induced membrane fusion by influenza hemagglutinin (HA) is proposed based
upon the hypothesis that the conformational change to the extended coiled coil creates a high-energy hydrophobic
membrane defect in the viral envelope or HA expressing cell. It is known that 1) an aggregate of at least eight HAs is required
at the fusion site, yet only two or three of these HAs need to undergo the “essential” conformational change for the first fusion
pore to form (Bentz, J. 2000. Biophys. J. 78:000–000); 2) the formation of the first fusion pore signifies a stage of restricted
lipid flow into the nascent fusion site; and 3) some HAs can partially insert their fusion peptides into their own viral envelopes
at low pH. This suggests that the committed step for HA-mediated fusion begins with a tightly packed aggregate of HAs
whose fusion peptides are inserted into their own viral envelope, which causes restricted lateral lipid flow within the HA
aggregate. The transition of two or three HAs in the center of the aggregate to the extended coiled coil extracts the fusion
peptide and creates a hydrophobic defect in the outer monolayer of the virion, which is stabilized by the closely packed HAs.
These HAs are inhibited from diffusing away from the site to admit lateral lipid flow, in part because that would initially increase
the surface area of hydrophobic exposure. The other obvious pathway to heal this hydrophobic defect, or some descendent,
is recruitment of lipids from the outer monolayer of the apposed target membrane, i.e., fusion. Other viral fusion proteins and
the SNARE fusion protein complex appear to fit within this hypothesis.
INTRODUCTION
Membrane fusion is a crucial event in a multitude of bio-
logical processes, and understanding the molecular mecha-
nism is a central goal of biology. The ectodomain of the
membrane fusion glycoprotein hemagglutinin (HA) of in-
fluenza virus, which requires low pH to initiate fusion, was
the first membrane fusion protein whose crystal structure
was solved (Wilson et al., 1981), and it remains the proto-
typical fusion protein (Skehel and Wiley, 1998; Sutton et
al., 1998; Baker et al., 1999). The key difference between
the “native” structure of HA and the low-pH structure is the
formation of an extended coiled coil starting from the N-
terminus of the native coiled coil and a helix-turn occurring
within the C-terminal end of the native coiled coil, near the
transmembrane domain (Carr and Kim, 1993; Bullough et
al., 1994; Chen et al., 1995). Recently, ectodomain core
complexes of other membrane fusion proteins have shown
remarkably similar equilibrium crystal structures with re-
spect to this coiled coil motif (Chan et al., 1997; Fass et al.,
1996; Weissenhorn et al., 1997, 1998; Caffrey et al., 1998;
Sutton et al., 1998; Skehel and Wiley, 1998; Baker et al.,
1999; Singh et al., 1999).
This has led to speculation that these proteins share a
common molecular mechanism for initiating membrane fu-
sion. The belief is that the formation of extensive coiled
coils can release adequate free energy to overcome the
barriers to membrane fusion. Curiously, the formation of the
extended coiled coil, which is the conformational change of
HA likely to release the most energy, has been speculated
solely to bring the HA2 N-terminus, aka the fusion peptide,
to the target membrane, a process that one would think to be
nearly spontaneous. However, the conformational change
speculated to form the high-energy membrane defect is the
helix-turn near the transmembrane domain. This is essen-
tially a rearrangement of hydrophobic interactions within
preexisting coiled coil domains and would release much less
energy than the formation of the extended coiled coil (Carr
and Kim, 1993; Bullough et al., 1994; Hernandez et al.,
1996; Weissenhorn et al., 1997, 1998; Skehel and Wiley,
1998). These assignments do not appear to optimally utilize
the free energy released by the conformational changes.
Correlating HA conformational changes with its fusion
mechanism requires a rigorous kinetic analysis of both. A
first step for the fusion mechanism has been accomplished
in Bentz (2000) where the data of Melikyan et al. (1995a)
were analyzed for the time required for the first fusion pore
to form (i.e., the first electrical conductivity event) across a
planar bilayer induced by bound HA expressing cells. These
kinetic data showed that the first fusion pore formed from
an aggregate of at least eight HAs, of which only two or
three had to undergo the “essential” HA conformational
change, which has a rather slow average halftime of 104 s.
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Here, the results of this kinetic analysis are coupled to the
proposal that the formation of the extended coiled coil of
HA is the defect forming conformational change. Mere
close apposition of lipid bilayers ( 1 nm) does not lead to
“spontaneous” fusion. A hydrophobic and/or curvature de-
fect in the membranes is required. Since only two or three
HAs need to transform slowly to initiate fusion, this
strongly suggests that the first destabilization is a hydro-
phobic defect, since creation of a bending defect should
require the concerted effort of many more HAs (Kozlov and
Chernomordik, 1998). We begin with the model for HA-
mediated fusion and other fusion proteins will be discussed
later.
HA conformations and fusion intermediates
In the physiological course of infection, virus bound to the
cell surface is endocytosed and exposed to low pH, which
induces two or three subsequent conformations in HA,
which are depicted in Fig. 1. The native structure of HA
(Fig. 1, conformation 1) is based upon the crystal structure
of the bromelain-released hemagglutinin ectodomain, BHA
(Wilson et al., 1981). HA is a homotrimer and each mono-
mer is composed of two polypeptide segments, designated
HA1 and HA2. The HA1 segments form sialic acid binding
sites, which mediate initial HA attachment to the host cell
surface. The HA2 segments form the membrane-spanning
anchor, the assembly domain of the homotrimeric structure,
and its amino-terminal region is required in the fusion
reaction (Gething et al., 1986).
Upon acidification, exposure of the amino terminus of
HA2, known as the fusion peptide, occurs (Fig. 1, confor-
mation 2). This change is rapid compared to fusion and is
required to promote fusion between the viral envelope and
the target membrane (Skehel et al., 1982; White and Wilson,
1987; Stegmann et al., 1990; Stegmann and Helenius, 1993;
Godley et al., 1992; Pak et al., 1994).
While there has been a long literature proposing that the
exposed N-terminal of HA next inserts into the target mem-
brane to start fusion (reviewed in Durell et al., 1997), it is
more accurate to say that HAs can have their fusion peptides
either suspended between the membranes or embedded in
the target bilayer or in their own bilayer (Bentz et al., 1990;
Gaudin et al., 1995; Shangguan et al., 1998; Kozlov and
Chernomordik, 1998). The fraction in each state probably
depends upon time and the real question is: Which state or
which sequence of states is on the “fusion pathway”?
Kozlov and Chernomordik (1998) and Bentz (2000) argue
that those HAs whose fusion peptides embed into the vi-
ral/HA expressing cell envelope are on the fusion pathway.
Reaching the target membrane represents a later step in the
process. Thus, the fusion peptide is shown here to be em-
bedded in the viral envelope and this is the population we
shall follow.
The second conformational change leads to the formation
of the extended coiled coil of HA2 (Fig. 1, conformation 3),
which was predicted by Carr and Kim (1993), proven for the
crystallographic structure of a fragment of BHA (TBHA2,
residues 38–175 of HA2 and 1–27 of HA1 held together by
the disulfide bond) by Bullough et al. (1994) and morpho-
logically observed on the intact virus by Shangguan et al.
(1998). In addition, Qiao et al. (1998) showed that site-
directed point mutations predicted to inhibit the formation
of the extended coiled coil did inhibit the fusion of eryth-
rocytes to HA expressing cells. This conformational change
relocates the N-terminus of HA2 10 nm toward the target
membrane, creates new stretches of coiled coil structure,
and should release the largest free energy of all the HA
conformational changes.
The crystal structure of TBHA2 (Bullough et al., 1994)
also shows that the C-terminus of the coiled coil of BHA
FIGURE 1 The conformations of HA. (1) This is the native conforma-
tion of BHA, adapted from Wilson et al. (1981). The globular HA1
headgroups sit on top of the spike-like HA2. Regions of -helix and coiled
coil are shown as cylinders. The bottom aggregate of -helices is the
transmembrane domain, striped and denoted TM. (2) Low pH releases the
HA2 N-terminus, also known as the fusion peptide, which is shown here as
embedded in the viral envelope, although other states are also possible. (3)
The transition to the extended coiled coil by HA2 causes dissociation of the
HA1 headgroups. (4) The helix-turn transition at the base of the original
coiled coil of HA2 found in the crystal structure of TBHA2 (Bullough et
al., 1994) is shown, with the hydrophobic faces aimed into the pockets
vacated by the fusion peptides. Whether this transition happens with
membrane bound HA is not yet known.
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has flipped up to a helix-turn between residues 106 and 112
of HA2 and an antiparallel -helical annulus from residues
113–129 of HA2, i.e., at the base of the extended coiled coil
(see Fig. 1, conformation 4). Basically, the C-termini of the
native coiled coil flip up so that their hydrophobic faces can
now fill the hydrophobic pockets evacuated by the fusion
peptides, thereby forming the annular helices around the
C-terminus of the low-pH coiled coil. This helix-turn tran-
sition, as yet unproven for membrane-bound HA, has been
proposed as a means of bringing the membranes together
(Bullough et al., 1994; Chen et al., 1995; Hernandez et al.,
1996; Carr et al., 1997; Weissenhorn et al., 1997, 1998;
Skehel and Wiley, 1998). However, since it only rearranges
preexisting hydrophobic domains of coiled coil to cover the
hydrophobic pocket evacuated by the fusion peptide, while
losing some hydrophobic contacts, it should not release
nearly as much free energy as the newly formed extended
coiled coil. The C-terminal helical extension of TBHA2
found in Chen et al. (1999) was not observed using the
original expression system (Bullough et al., 1994), which
suggests that it is due to a still weaker interaction than the
core helix-turn. Whether this extension reflects the in vivo
structure is not known. Obviously, even assuming that the
helix-turn occurs on the viral HA, the order of the changes
to extended coiled coil and to the helix-turn transition isn’t
known.
The current problem in HA-mediated fusion is to corre-
late these well-known “individual” low-pH conformational
changes of HA fragments with the “communal” intermedi-
ates of fusion. Most proposed HA-mediated fusion mecha-
nisms are composed of four distinct intermediates, subse-
quent to close apposition of the membranes and the low
pH-induced exposure of the HA2 N-terminus (Bentz, 1992,
2000; Blumenthal et al., 1996; Chernomordik et al., 1998).
Currently, these intermediates are:
1. Aggregates of HA, which are either preformed or form
rapidly subsequent to acidification.  denotes the mini-
mal aggregate size required to sustain the formation of
the next step;
2. The first fusion pore defined by the first conductivity
(2–5 nS) across the membranes. Additional flickering
pores follow that lead to the formation of a terminally
open pore;
3. The lipidic channel, which is monitored by lipid dye
transfer between membranes;
4. The fusion site, which is monitored by aqueous contents
mixing (e.g., fluorophors) and the stable joining of the
two membranes and complete aqueous contents mixing.
It is generally accepted that an aggregate of HAs is
required to form the fusion site (Ellens et al., 1990; Bentz et
al., 1990; Bentz, 1992, 2000; Blumenthal et al., 1996;
Danieli et al., 1996). The analysis of the data of Melikyan et
al. (1995a) in Bentz (2000) showed that rapid HA aggrega-
tion followed by a slow “essential” conformational change
of the HAs within the aggregate fitted the data far better
than the opposite assumption of fusion, which is rate-lim-
ited by slow HA aggregation. The mechanism of rapid HA
aggregation could be adhesion of the fusion peptides within
the aqueous space (Ruigrok et al., 1988), and/or membrane
curvature minimization due to fusion peptides embedded in
their own (viral or HA expressing cell) membrane (Kozlov
and Chernomordik, 1998), which is consistent with the
hypothesis made here, and/or some other interaction.
Since there is conductivity across the membranes at the
first fusion pore, in the absence of lipid or aqueous dye
mixing, this implies that initially there is restricted lipid
flow into the fusion site from the viral or HA expressing cell
bilayer (Tse et al., 1993; Zimmerberg et al., 1994; Cherno-
mordik et al., 1998). Furthermore, the step from first fusion
pore to lipid channel appears to be the committed step to
fusion, since once sustained flickering occurs complete fu-
sion usually follows. Chernomordik et al. (1998) also dis-
cuss other side reactions from the first fusion pore that do
not lead to fusion, further implicating the transition from
first fusion pore to lipid channel as the committed step of
fusion.
Kemble et al. (1994) and Melikyan et al. (1995b, 1997)
found that GPI-linked HAs on cells only induce outer
monolayer mixing, thus showing the necessity of the full
transmembrane domain for achieving the committed step
for fusion. Other viral fusion proteins appear to require
flexibility in their transmembrane domains for activity
(Cleverley and Lenard, 1998). Chernomordik et al. (1998)
suggested that the function of the HA transmembrane do-
mains is to restrict the flow of lipids into the fusion site by
a close approach due to aggregation of the transmembrane
domains. The GPI-linked HAs may fail to promote fusion
because they fail to restrict this flow. While the evidence of
the state of restricted lipid flow is clear (Tse et al., 1993;
Zimmerberg et al., 1994; Chernomordik et al., 1998), the
real question is: Why is restricted lipid flow important for
fusion?
The committed step of HA-mediated fusion
Following the paradigm for enzymology, the key to under-
standing the committed step of any multistep process is to
understand how the “enzyme” is complementary to the
“transition state.” For HA-mediated fusion, we ask what
kind of “transition” state can be stabilized by restricting the
flow of lipids from the viral bilayer into the fusion site. The
highest energy state in fusion will be the initial destabiliza-
tion or disruption of the apposed monolayers, which is
resisted by the hydrophobic effect and bilayer curvature
effects (Siegel, 1993a, b; Chernomordik et al., 1995). The
only substantial available energy to facilitate this process,
aside from thermal energy, is the conformational changes of
HA (see Fig. 1, conformations 3 and 4).
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Fig. 2 is the hypothesis for fusion mediated by coiled
coils. Fig. 2 A shows the aggregate of HAs with fusion
peptides embedded in the viral envelope, which is the start-
ing point of the model of Kozlov and Chernomordik (1998)
for HA aggregation and fusion. While other HAs may have
their fusion peptides in the aqueous media or in the target
membrane, here we will follow the path of those HAs that
begin with their fusion peptides embedded in their own
envelope. These HAs seem most likely to blaze the fusion
pathway.
The conformational change to the extended coiled coil is
assumed to occur next (Skehel and Wiley, 1998; Baker et
al., 1999), as depicted in Fig. 2 B. This must extract the
fusion peptides from the outer monolayer of the viral enve-
lope and send them toward the target membrane. For those
HAs in isolation or in aggregates not in the restricted flow
state, the evacuated space in the viral outer monolayer will
be quickly filled by lipid diffusion and little or nothing
significant will happen on the viral envelope. Presumably
these fusion peptides would embed in the target membrane,
which would explain the hydrophobic binding of virions to
target membranes, e.g., liposomes, which occurs before
fusion (Stegmann and Helenius, 1993; Brunner and Tsure-
dome, 1993; Chernomordik et al., 1998; Bentz, 2000).
However, for those fusion peptides embedded within the
site of restricted lipid flow, the evacuated space cannot be
refilled instantly since the aggregated HA transmembrane
domains and the remaining embedded fusion peptides
would block the flow. Thus, a hydrophobic defect is created.
It is important to note that because the depiction shown in
Fig. 2 B is to scale, albeit crudely, it shows that the initial
hydrophobic defect must expose both acyl chains and HA
transmembrane domains to the water. Thus, the surface of
the defect is a mixture of a hydrophobic lipid and protein.
This will become very important as this hypothesis evolves.
The first obvious question is whether there is enough
energy released in the formation of the extended coiled coil
to extract the fusion peptide and produce this hydrophobic
defect. The answer is yes, within the limits of our current
knowledge. A slightly more sophisticated answer is that the
conformational change shouldn’t happen before the HAs
can aggregate and establish a state of restricted lipid flow.
The free energy released by the formation of the extended
coiled coil should be less than that required to form the
hydrophobic defect by enough to give the free energy of
activation needed to slow the step down adequately.
The free energy released by the formation of the extended
coiled coil the size of that formed by HA is 30 kcal/
mol(HA) (Dieckmann et al., 1998; Kozlov and Cherno-
mordik, 1998). Thus, the transformation of two or three
HAs to extended coiled coils could provide up to 60 or
90 kcal/mol for the creation of the hydrophobic defect.
Obviously, not all of this free energy may be available for
defect stabilization, but that is not a practical concern at
present.
The estimate for how much free energy is required to
make fusion is more involved and less definite. To begin,
little free energy should be required to move the fusion
peptide from viral membrane to target membrane, since the
hydrophobic portion of the peptide is embedded in a bilayer
at both ends. Thus, the free energy released by the confor-
mational change is only needed to create the hydrophobic
defect in the outer monolayer of the viral membrane.
The next step is to estimate the size of this defect. Three
embedded loops of an -helical fusion peptide should dis-
place two to three phospholipids. The simple depiction of
the central HAs in the fusion site in Fig. 2 B shows only one
fusion peptide per HA within the area of lipid flow restric-
tion and the other two fusion peptides outside. This condi-
tion is likely to be general, since the hydrophobic defect will
be small, only a few HAs within an aggregate could border
it. It could also be that an HA has only one or two of its
fusion peptides embedded, rather than all three, but this is
not a practical point. It will be assumed that only one fusion
peptide must be extracted from the site of restricted lipid
flow per HA.
Since two to three HAs must undergo the essential con-
formational change to initiate fusion (Bentz, 2000), thereby
removing two to three fusion peptides from site of restricted
lipid flow, the size of the defect would be of the order of
four to nine phospholipids, as depicted in Fig. 2 B. For
simplicity, we can assume that the lipids are completely
laterally displaced by the peptide, i.e., no tilting of acyl
chains, which probably overestimates the surface area of the
defect. We will consider the effect of tilted fusion peptides
in the Discussion. Thus, a cylindrical defect of10–20 nm2
would be formed, 1.5 nm sides (the length of the acyl
chains) and a 1–1.4 nm radius, assuming smooth (not mo-
lecular) surfaces.
The final step is to estimate the free energy required to
create a defect of this size. This estimate is even more crude,
not only because the parameters for this type of “structure”
are not known as rigorously, but also because the molecular
surface of the hydrophobic defect must be a mix of acyl
chains and hydrophobic amino acid side chains of the HA
transmembrane domains. Ironically, it appears that this
mixed lipid/protein surface may be required both by the
closeness of packing of HAs required to restrict lipid flow
and by the energetics of forming the hydrophobic defect.
This provides a natural role for the transmembrane of fusion
proteins.
We can begin with an underestimate of this free energy.
The energy required to create a pore this size in a pure lipid
monolayer, i.e., half that required for a bilayer, by osmotic
shock or electric field pulse is 40–55 kcal/mol, assuming
standard values for surface tension,  2 103 N/m, and
edge energy, A˜ 1011 N (Winterhalter, 1999). It is clearly
less than the 60 to 90 kcal/mol available from the HA
conformational change, and this gets us over the first hurdle.
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FIGURE 2 The hypothesis for HA-mediated fusion. Lipids and proteins are depicted to scale. Only the conformations of HA2 are shown, i.e., for visual
clarity the HA1 headgroups are omitted. (A, left) The proposed conformation of HA2 after the fusion peptide is exposed, like Fig. (1, conformation 2). (A,
middle) Side view of an aggregate of HAs, with their fusion peptides embedded into the viral envelope. (A, right) A view from the top of the HA-containing
bilayer showing the lipid headgroups, the tops of the transmembrane domains, and the embedded fusion peptides. (B, left) The proposed conformation of
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Now, we can obtain an overestimate for the free energy
required. It is likely that the alkane/water interfacial tension
value of 5 102 J/m2 7.2 (kcal/mol-nm2) (Small, 1986)
overestimates the water/acyl chain interaction within this
defect, but it is a rigorous value. If the whole defect were
purely lipidic, then the estimate for the free energy would be
84–142 kcal/mol, i.e., 24–52 kcal/mol more than the HA
conformational change could provide. However, the hydro-
phobic defect is also composed of exposed transmembrane
amino acid side chains. We can use the value of 2.3 kcal/
mol-nm2 of exposed nonpolar amino acid side chains to
estimate their contribution (Wimley et al., 1996). Assuming
a 1:1 composition of acyl chains and amino acid side chains
on the sides of the cylindrical defect surface and pure lipid
on its base (from the tail ends of the acyl chains of the inner
monolayer), which is arbitrary but about right from Fig. 2 B,
yields a free energy for formation of the hydrophobic defect
of 62–110 kcal/mol. This overestimate is just a little more
than the estimated available free energy from the confor-
mational change to the extended coiled coil.
While these estimates are necessarily crude, they imply
that the extraction of the virally embedded fusion peptides is
energetically possible. It can be argued that not all of the
energy from the protein conformational change might be
available. However, it is also true that the transition time of
the essential conformational change is at least five to seven
orders of magnitude slower that expected for formation of a
coiled coil, which implies an activation free energy of
7–10 (or more) kcal/mol (Bentz, 2000). Thus, the bottom
line is that the hydrophobic defect depicted in Fig. 2 B can
be formed by two to three HAs undergoing the conforma-
tional change to the extended coiled coil, in part because the
transmembrane domains of the HAs are part of this hydro-
phobic defect. This will be discussed further below.
To test whether the formation of the extended coiled coil
creates a hydrophobic defect in the viral (or HA expressing
cell bilayer) will be difficult, but a first step could entail the
usage of detergents that do not impart significant curvature
to the bilayers, such as bile salts, to determine whether they
can block destabilization differently than lysoPC, which
alters the intrinsic curvature of the monolayers (Cherno-
mordik et al., 1997–1999). That is, these detergents would
be expected to “heal” the hydrophobic defect, without hin-
dering the ability of curvature-dependent lipid intermedi-
ates, e.g., stalks, proposed by others and below to mediate
other steps of fusion. Obviously, a kinetic analysis would be
required to determine which fusion intermediate was
affected.
Returning now to the hypothesis, the HAs surrounding
the hydrophobic defect cannot immediately diffuse apart
(thereby admitting lipids from the viral outer monolayer),
since that would require reversing the aggregation mecha-
nism and initially require expanding the surface area of
hydrophobic defect by inclusion of pure acyl chains. The
aggregate of HAs has become a dam holding the lipids on
the outside. Clearly, this is a very high-energy intermediate
that is stabilized by the restricted flow of lipid due to the HA
aggregate (Tse et al., 1993; Zimmerberg et al., 1994; Cher-
nomordik et al., 1998). The other HA-HA interactions that
stabilize this “dam” are the exposed fusion peptides of HAs
that haven’t yet undergone the conformational change to the
extended coiled coil.
The next obvious question is what would be the halftime
for maintenance of the restricted lipid flow state relative to
the halftime for the excursion of lipid molecules from the
target membrane. The only reasonable means of estimating
this time is a very lengthy and expensive molecular dynam-
ics simulation, given the number of atoms in (roughly) eight
HAs, 200 phospholipids, and 104 or more water molecules.
Even then, the halftimes would be extremely sensitive to the
distance of separation between the bilayers. While it would
be desirable to know the energy cost of expanding this HA
barrier enough to admit lipid flow, the expansion would
occur on a molecular-size scale. A calculation based upon
macroscopic theories would be quite unreliable and it
wouldn’t yield a halftime of stability for the defect in any
event. However, one element of this calculation seems
predictable. It is likely that the free energy per unit area of
exposure of acyl chains to water will remain greater than
that for the side chains of transmembrane amino acids.
Thus, expansion of the defect will be more energetically
costly, per unit area, than its original formation, since ex-
pansion will come nearly completely from exposure of new
acyl chains. Obviously a conclusive answer will require an
extensive, well-planned hierarchical calculation, followed
by the right experiments. It is also possible that the mor-
phology of the hydrophobic defect could change, as the
lipids facing it rearrange over time, without substantially
reducing the free energy.
The hydrophobic defect can be relieved by recruitment of
lipids from the outer monolayer of the apposed target mem-
brane, aka the first step of fusion. This process would
HA2 once the transition to the extended coiled coil occurs for the HA monomers whose fusion peptides are within the fusion site, like Fig. (1, conformation
3). (B, middle) The space evacuated by the fusion peptides fills immediately outside the fusion site, but the acyl chains remain exposed within the fusion
site due to the restricted lipid flow, i.e., depicting the hydrophobic defect. (B, right) The view from the top with this open space depicting the hydrophobic
defect. (C) The formation of a lipidic stalk between the apposed membranes, formed by the lipids of the target membrane filling in the hydrophobic void.
This stalk could form within HAs either standing up (on the left) or lying down (on the right, with a much lower free energy), perhaps facilitated by a
helix-turn transition of one HA2 monomer. No view from the top is shown, as it is identical to the right side of (B). (D) The formation of the fusion site,
with communication of aqueous compartments, perhaps due to the completion of the helix-turn conformational change.
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probably start with movement of individual or small aggre-
gates of lipids. How this happens isn’t known; however,
lipids show substantial positional fluctuations on a subnano-
second time scale (Husslein et al., 1998). It is possible that
the fusion peptides now embedded in the target membrane
would facilitate the movement of the lipids from the target
membrane to the hydrophobic defect in the viral envelope
(Durell et al., 1997). This molecular translocation would
continue until a relatively stable contiguous structure forms
between the outer monolayers.
For pure lipid systems the equilibrium formation of a
lipid stalk appears to require the least energy for connecting
apposed outer monolayers (Kozlov et al., 1989; Siegel,
1993a, b; Chernomordik et al., 1995, 1997). Chernomordik
et al. (1998, 1999) and Kozlov and Chernomordik (1998)
have proposed that the lipid stalk is an intermediate of
HA-mediated fusion for this reason. However, within the
HA fusion site, whether it forms from a nucleation of lipids,
as proposed here, or by the continuous bending of lipid
monolayers, as proposed by Kozlov and Chernomordik
(1998), is a very important question, since it’s answer will
show where the energy of the HA conformational change is
first spent.
Fig. 2 C shows this stalk, either with the HAs erect (on
the left, which seems too great a distance) or tilted (on the
right). Tilting has been reported in reconstituted systems
(Tatulian et al., 1995; Wharton et al., 1995; Gray and
Tamm, 1997, 1998) and the energy cost of forming the
shorter stalk would be much less. It could be that the
helix-turn transition could cause this tilt, by occurring first
for just one of the HA coils, as depicted on the right side of
Fig. 2 C. That the crystal structure of TBHA2 shows all
three helix-turns may simply reflect the symmetry of the
fragment rather than a requirement for fusion. Again, it is
not known that this helix-turn transition occurs on intact
HA, but if it does, this model requires that HA remains
upright through the formation of the extended coiled coil so
that it can extract the embedded fusion peptide. This is
structurally easy to believe from the arguments of Kozlov
and Chernomordik (1998).
The final step in this process is the transformation of the
stalk to form the fusion site, showing lipid mixing and then
the contents mixing. Other intermediate steps are possible.
While this step has been considered in some detail with pure
lipid systems (Kozlov et al., 1989; Siegel, 1993a; Cherno-
mordik et al., 1995), the fact that the hemifused state can be
stabilized in HA-mediated fusion suggests that the protein
strongly affects the process. The tension provided by this
nascent helix-turn transition could facilitate the transforma-
tion of the stalk to a fusion pore. The helix-turn transition at
the base of HA2, residues 104–112, if effected on the intact
virus, would force the base of the HA trimer ectodomain
down onto the top of its transmembrane domain (Fig. 1,
conformation 4). Since the N-terminus of HA2 would now
be tethered to the target membrane, this tension on the
transmembrane domain would tend to pull the stalk apart
and open the fusion site, as depicted in Fig. 2 D.
DISCUSSION
This hypothesis provides a simple and direct transduction of
the energy released by the formation of the coiled coil to the
energy needed to create and stabilize the high-energy inter-
mediates of fusion. The committed step in influenza HA-
mediated fusion is proposed to begin with an aggregate of
HAs (at least 8) with some of their HA2 N-termini, aka
fusion peptides, embedded into the viral bilayer. These HAs
are packed so closely that lipids from the viral envelope are
restricted from diffusing into the center of the aggregate.
The conformational change of HA to the extended coiled
coil extracts the fusion peptides from the viral bilayer.
When this extraction occurs from the center of the site of
restricted lipid flow, it exposes acyl chains and parts of the
HA transmembrane domains, i.e., the hydrophobic defect.
This is the “transition state” of the committed step of fusion.
It is stabilized by a “dam” of HAs, which are inhibited from
diffusing away. Recruitment of lipids from the apposed
target membrane can heal this hydrophobic defect, initiating
lipid mixing and fusion.
The obvious question is whether the free energy needed
to create the hydrophobic defect proposed in Fig. 2 B can be
provided by the conformational change to the extended
coiled coil. No rigorous answer is possible, but the crude
estimate is yes, just about. Actually, the free energy sup-
plied by conformational change should be several kcal/mol
less than that required to form the hydrophobic defect, to
make sure that the conformational change doesn’t occur
before an adequately large HA aggregate can form to sus-
tain lipid flow restriction. While evolution could certainly
have produced a more energetic conformational change for
HA, e.g., by making the extended coiled coil longer, the
fusion efficiency of that “faster” HA would be predicted by
this model to diminish. This is a clear source of natural
selection adequate to explain the high homology of the HA
loop regions. In models where the formation of the extended
coiled coil is assigned solely to bring the fusion peptide to
the target membrane, the source of the natural selection
needed to maintain the homology can only be theoretical,
e.g., possible packing constraints or extra energy required
for synthesis and folding. Of course, if the conformational
change took much longer, the virion would never escape the
endosomal/lysosomal pathway.
The HA transmembrane domains are required to be part
of the hydrophobic defect because the HA aggregate must
be closely packed enough to restrict lipid flow. Having the
transmembrane domains as part of the hydrophobic defect
also lowered the free energy required for its creation. This
observation alone could explain the reported importance of
transmembrane domain flexibility on viral fusion protein
activity (Cleverley and Lenard, 1998). A rigid transmem-
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brane domain should not participate in the defect surface as
well, i.e., to lower its free energy of formation.
There is some morphological information about the HA
fusion site. Kanaseki et al. (1997) have presented a wide
array of beautiful electron micrographs of influenza virions
(A/PR/8) fusing with glycophorin-containing liposomes.
Unfortunately, there are no data showing the kinetics of
fusion under the same conditions as the electron micros-
copy. Nevertheless, the fusion sites appear as protrusions
from the outer monolayer of the liposome target membrane
and fusion appears to start in the center of these sites with
the liposome target membrane being pulled toward the viral
membrane (see their Figs. 6 and 8). This would be expected
from the model proposed here. These protrusions are of the
order of 10 nm in diameter, which would be the diameter of
a collar of roughly eight HAs, although the thickness of the
shadowing makes quantitation very uncertain.
The “essential” conformational change for fusion
Of course, it remains to be proven that the formation of the
extended coiled coil is the “essential” conformational
change for the formation of the first fusion pore identified
kinetically in Bentz (2000). As yet, no structural technique
has succeeded in showing a rigorous correlation between
the kinetics of fusion intermediate formation and the kinet-
ics of extended coiled coil or helix-turn formation (Ko¨rte et
al., 1997, 1999; Shangguan et al., 1998). Qiao et al. (1998)
found that mutations predicted to hinder the extended coiled
coil formation did inhibit fusion, suggesting that this con-
formational change might be necessary for fusion, although
other conformational changes could have been responsible.
Puri et al. (1990) showed that incubation of isolated virions
(A/Japan/305/57 strain) at low pH resulted in no substantial
morphological change in HA over the time range where
virion fusion was studied. Shangguan et al. (1998) showed
with the A/PR/8/34 strain that virions could fuse only before
a morphological change consistent with the formation of the
extended coiled coil was evident on the isolated virions.
Ko¨rte et al. (1999) corroborated this finding with a cryo-
electron micrograph of X31 virions, suggesting that loss of
fusion activity correlated with the formation of extended
coiled coil. Thus, the formation of extended coiled coil
appeared not to be a precursor of fusion (Shangguan et al.,
1998). If the extended coiled coil is necessary for fusion,
then destabilization must be coupled directly to the motion
of the conformational change.
The time constant for the “essential” conformational
change leading to the first fusion pore was found to be104
s, on average (Bentz, 2000). The morphological changes
indicative of formation of the extended coiled coil on the
isolated PR8 virions required 103 s (Shangguan et al.,
1998). However, the cell lines used in Melikyan et al.
(1995a) express the Japan strain of HA, which has slower
and less complete inactivation kinetics than PR8 (Puri et al.,
1990; Ko¨rte et al., 1997, 1999). Thus, the similarity of time
scales is striking. This suggests that the extended coiled coil
morphology visualized in Shangguan et al. (1998) is due to
the essential conformational change for first-fusion pore
formation.
How can fusion happen in 100–200 s, when the “essen-
tial” conformational change for HA occurs only in 104 s, on
average. The reason is that HA refolding kinetics must be
broadly distributed, i.e., some sooner and some later, and
that fusion experiments of Melikyan et al. (1995a) only
monitor the very first of hundreds or thousands of fusogenic
HA aggregates (depending upon HA surface density),
which succeed in forming the first fusion pore (Bentz,
2000). The essence of any fusion experiment is to observe
only the first of a large ensemble of HA aggregates to
succeed.
Integration of fusion models
Kozlov and Chernomordik (1998) have proposed a mecha-
nism for HA aggregation and fusion that starts with the
fusion peptide embedded in the viral envelope. They esti-
mate that while one HA could not deform the membrane, an
aggregate could after one or more of the heptad repeats of
the extended coiled coil form, thereby holding the mem-
brane up in a locally curved state which is held in place by
the binding strength of the heptad repeats. This membrane
deformation should continue, as more heptad repeats form
in the extended coiled coil, until the curvature energy ex-
ceeds the binding energy of the next heptad repeat. The HAs
should become tightly packed, i.e. perhaps until the state of
restricted lipid flow is reached.
Their model continues by proposing that the six or more
HAs within the aggregate (with fusion peptides embedded
in the viral envelope) simultaneously tilt away from the
center, forming a dimple of bilayer that is reaching toward
the target membrane with a great deal of bending energy at
the tip. They argue that this tilting does not cost much
energy and propose that this structure continues to grow
from the viral bilayer until it forms a “stalk” connecting the
outer bilayers.
However, the model of Kozlov and Chernomordik (1998)
has no role for the state of restricted lipid flow and no
obvious explanation for the fact that only two or three HAs
within the aggregate need to transform slowly in order for
the first fusion pore to form (Bentz, 2000). It could be
argued that the remaining four or three, or more, HAs tilt
rapidly and cooperatively, but that doesn’t appear compat-
ible with their calculation of the mechanical forces needed
to create and stabilize the dimple. Furthermore, for the
dimple to grow toward the target membrane requires more
lipids to flow into the site from the viral bilayer, which
wouldn’t occur if the lipid flow becomes restricted.
There is an appealing combination of these two models.
Beginning with the model of Kozlov and Chernomordik
Fusion Mediated by Coiled Coils 893
Biophysical Journal 78(2) 886–900
(1998), the HAs in the fusion site will tilt and begin to form
the dimple toward the target membrane. The collar of HAs
will tighten until the site becomes lipid-flow-restricted.
Then the dimple can grow no further. The tension on the
fusion peptides will cause some of them to pull out the viral
envelope (perhaps one hydrophobic residue at a time, which
should require less energy or force than removal of the
whole peptide at once), and move to the target membrane
following the formation of the extended coiled coil. This
produces the unstable site shown in Fig. 2 B. The stalk
proposed by Kozlov and Chernomordik (1998) could as-
semble from the lipids moving from the target membrane to
heal the hydrophobic defect.
An experimental dissection between the model proposed
by Kozlov and Chernomordik (1998) and the one proposed
here would begin with increasing the hydrophobicity of the
fusion peptide, e.g., mutants with more hydrophobic side
chains on the appropriate amino acids of the fusion peptide.
The model of Kozlov and Chernomordik (1998) would
predict equal or better fusion. The model proposed here
would predict that eventually fusion would diminish, as the
fusion peptides became too hydrophobic to be pulled out by
the extended coiled coil. Interestingly, Qiao et al. (1999)
found that point mutations of the HA2 N-terminal glycine,
at the end of the fusion peptide, to more hydrophobic
residues reduced (for G1A) and abolished (for G1V) fusion
of HA expressing cells. More hydrophilic residues also
reduced (G1S) or abolished (G1E) fusion, although perhaps
for different reasons. Further studies will be needed before
any conclusions can be reached. In this regard, the work
suggesting that viral fusion peptides appear to embed in
bilayers at a oblique angle (Peuvot et al., 1999), if correct
for the intact HA during fusion, may well reflect an opti-
mization between maximizing the “footprint” of the peptide
in the viral outer monolayer, to create the largest defect
upon extraction, while maintaining the hydrophobicity of
the fusion peptide insertion, to allow extraction with the
required kinetics to sustain fusion.
Resolution of paradoxical results
The fusion model proposed here is consistent with both the
common results of HA-mediated fusion and with the para-
doxical results. A recent interesting result is that HA ex-
pressing cells lose fusogenicity when they are inflated at
24°C, but not at 32°C (Markosyan et al., 1999). Their
explanation is that bilayer expansion and thinning causes an
inhibition of the dimpling of the membrane before stalk
formation, along the lines of the model of Kozlov and
Chernomordik (1998). However, the hypothesis presented
here gives an alternative and testable explanation. Penetra-
tion of peptides into lipid monolayers shows increased
binding as surface pressure is reduced (Rafalski et al.,
1991). This suggests that embedded peptides will require
increased energy to be extracted from the expanded bilay-
ers, which would certainly inhibit fusion by this hypothesis.
The energy balance estimates presented above strongly sug-
gest that a modest increase in the binding constant of the
peptide could defeat the efforts of the extended coiled coil
to extract the embedded fusion peptide. Furthermore, it
seems likely that peptide binding would decrease with in-
creasing temperature, which would be consistent with the
data of Markosyan et al. (1999), if peptide extraction is the
explanation.
A truly paradoxical result was found in Alford et al.
(1994). The kinetics of fusion of influenza virus with phos-
phatidylethanolamine (PE)/phosphatidylcholine (PC)/gly-
cophorin liposomes did not respond to the temperature of
hexagonal HII phase transition temperature, TH, of the lipids
composing the target membrane. If fusion required bilayer-
bilayer contact, then the fusion rate should have increased at
TH (Bentz et al., 1987). Thus, the fusion between the virions
and the glycophorin containing liposomes did not appear to
require bilayer-bilayer contact, a suggestion at odds with
other models of HA-mediated fusion. Furthermore, the fu-
sion kinetics were the same whether the target membrane
lipids were pure PE or (1:2) PE/PC, and were much slower
when the target membrane lipids were pure PC. Because the
fusion kinetics did not depend smoothly on PC/PE compo-
sition, the fusion mechanism appeared indifferent to the
known material properties of the lipid bilayers (Ellens et al.,
1989; Alford et al., 1994), a suggestion even more at odds
with other models of HA-mediated fusion. The hypothesis
proposed here eliminates these inconsistencies, since the
initial contact would occur between a hydrophobic defect
and the target membrane, which would not depend upon the
energetics of close approach of the lipid headgroups.
This hypothesis for protein-mediated fusion by coiled
coils largely depends upon exposed hydrophobic surface,
like that proposed for the fusion of pure PC liposomes (Lee
and Lentz, 1997). The highly curved bilayers of sonicated
PC liposomes (30 nm diameter) have substantial surface
exposure of acyl chains and they will fuse spontaneously
after polyethyleneglycol (PEG)-induced aggregation. Large
unilamellar liposomes (LUV, 100 nm diameter) made of
pure PC do not show fusion. However, Lentz et al. (1998)
showed that LUVs with some of the outer monolayer lipids
removed showed limited fusion. Furthermore, while the
fusion peptide of HA is required for fusion, the free peptide
alone inhibits the fusion of PC LUV, probably by decreas-
ing the bilayer surface hydrophobicity of the PC membranes
(Lentz et al., 1998). Likewise, the free peptide alone inhibits
the fusion of predominantly PE membranes, probably by
increasing the spontaneous radius of monolayer curvature of
these bilayers (Siegel and Epand, 1998). In both cases, the
free peptide will embed in the liposome bilayer and stay
there. The hypothesis proposed here centers on fusion being
due to removing the fusion peptide from the viral envelope
at the right time.
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It was believed that the HA fusion reaction should be
nonleaky, until recent experiments proved otherwise
(Shangguan et al., 1996; Blumenthal and Morris, 1999).
There remains a belief that this leakage is an experimental
artifact, not relevant to the virion. However, the fusion
mechanism proposed here could generate leakage easily.
The important question is whether the same site can leak
and then reseal by fusion, or whether some sites fuse while
other sites lyse.
The extent to which HA-mediated fusion is leaky appears
to depend upon the assay and the membrane system. For
example, Shangguan et al. (1996) found that influenza viri-
ons fusing with 0.1 m PC/ganglioside liposomes was lytic,
i.e., all contents (up to 10 kD dextran) were lost at the same
time as lipid mixing. Leakage of calcein from liposomes
induced by influenza virus was evident in the data of
Gu¨nther-Ausborn et al. (1995), although this result wasn’t
discussed. Chernomordik et al. (1997, 1998) found that HA
expressing cells fusing with dye-loaded erythrocyte ghosts
showed substantial, but not necessarily complete, contents
mixing. Leakage was not specifically monitored. Blumen-
thal and Morris (1999) detected leakage with basically the
same system, either at the same time as lipid mixing (for
some cells) or delayed (for other cells).
Blumenthal and Morris (1999) speculate that fusion of
the first site is nonleaky and leakage is due to “damage”
from subsequent fusion sites forming. However, on average,
leakage by any mechanism should be delayed compared
with lipid mixing as the size of the area of contact between
the apposing membranes increases, since leakage requires
escape from the area of contact while lipid mixing is local.
If the fusion site first leaks and then reseals following
fusion, then the same observations would be made. If the
fusion site is near the edge of the area of apposition, then
leakage would occur at the same time as lipid mixing. If the
fusion site is near the center of the area of apposition, then
leakage would occur later than lipid mixing. The area of
apposition between a virion and a liposome is obviously
much smaller that that between an HA expressing cell and
an erythrocyte, hence leakage from an LUV would expected
to be coincident with lipid mixing with the virion if the
fusion site leaks then fuses. Furthermore, a 0.1 m liposome
could lose its entire contents (0.5  1018 l) during the
process, while the same volume loss from an erythrocyte
would be insignificant. This can explain the observation of
Shangguan et al. (1996). Qiao et al. (1999) observed leakage
after first fusion pore formation, via whole cell capacitance
measurements, but the reverse sequence could probably not
be observed since leakage would overwhelm the first fusion
pore signal. Thus, the kinetic analysis of the leakage data is
not yet refined enough to determine whether or not leakage
and fusion happen at different sites.
Some data cannot be explained by the hypothesis. Lipo-
some fusion has been induced by an 11-amino acid syn-
thetic peptide when tethered to a lipid (Martin et al., 1999),
and Epand et al. (1999) have claimed that a fragment of HA
with a preformed extended coiled coil can induce liposomes
with a nearly isotropic phase composition of lipids to un-
dergo limited liposome-liposome lipid mixing. It remains to
be shown that these systems follow the same path for
bilayer destabilization as full-length HA in a membrane.
Extension of the hypothesis to other
fusion proteins
Since other viral fusion proteins show evidence of extended
coiled coils as part of their core equilibrium structures, it has
been widely speculated that a basic motif of viral fusion
proteins involves this “spring-loaded” conformational
change (Carr and Kim, 1993; Bullough et al., 1994; Carr et
al., 1997; Caffrey et al., 1998; Weissenhorn et al., 1997,
1998; Skehel and Wiley, 1998; Baker et al., 1999; Singh et
al., 1999). Two key revisions to that speculation are pro-
posed here: 1) that the initial defect (which requires high
free energy) is formed by the conformational change to the
extended coiled coil (Figs. 1, conformation 3; and 2 B),
which should release the most free energy; and 2) the
helix-turn transition to form the annular helical domains
(assuming it occurs) should be responsible for a lower-
energy process, such as bending the protein to facilitate the
formation of the lipidic stalk or/and rupturing the stalk
structure to permit lipid and aqueous contents mixing.
The robustness of this hypothesis can be seen by consid-
ering the paramyxovirus simian parainfluenza virus 5 fusion
protein (Baker et al., 1999), denoted SV5 F, whose core
ectoplasmic fragment was recently solved. This is a good
example because it is rather different from HA. The authors
note that this SV5 F fragment, while showing a very similar
coiled coil motif as that found with HA2, gp41, and other
viral fusion protein cores, does differ in three respects,
which they suggest implies a novel model for driving the
fusion reaction. These differences in the structure of the
SV5 F protein are (Baker et al., 1999):
1. The core coiled coil structure appears to extend into the
fusion peptide of the F protein, rather than there being a
linker between the N-terminal heptad repeat domain and
the fusion peptide. Chen et al. (1999) have observed a
lengthening of the extended coiled coil for an HA frag-
ment using a different expression system, although it
doesn’t yet reach the fusion peptide;
2. There is a small linker between the transmembrane do-
main and the C-terminus of the core coiled coil domain,
which can be deleted, as opposed to longer linkers for the
other fusion proteins. Interestingly, McNew et al. (1999)
have extended the linker in the SNARE fusion system,
discussed further below, and found that fusion dimin-
ished;
3. There is a long intervening polypeptide chain (250
AA) between the two heptad repeat domains, as opposed
to no or small ordered intervening chains.
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While it is not known how these structural differences
may affect fusion, they appear much less significant in light
of the model proposed here assuming, of course, that SV5 F
does fuse like HA. In the first case, if the extended coiled
coil forms after the fusion peptide has been removed from
the viral envelope, then the overlap of the coiled coil do-
main and the fusion peptide would only affect the evolution
of the nascent fusion site, not its initiation. Thus, the pri-
mary function of the extended coiled coil remains the same.
In the second case, the linker to the transmembrane domain
is important to the model proposed here only when it
becomes so long that the apposed membranes are too far
apart for the lipids from the target membrane to reach the
hydrophobic defect in time. The helix turn could cleave the
lipidic stalk, as speculated in Fig. 2 D, and a shorter linker
might facilitate this process. In the third case, the long
intervening polypeptide chain may simply facilitate the
tilting of the protein, as suggested by Baker et al. (1999) and
shown schematically in Fig. 2 C, on the right.
A model for fusion mediated by coiled coil proteins must
be able to explain the ability of peptides homologous to
coiled coils, aka heptad repeat domains, to inhibit fusion
(Wild et al., 1994; Jiang et al., 1993; Lu et al., 1994;
Munoz-Barroso et al., 1998; Joshi et al., 1998). These
peptides are thought to competitively inhibit the formation
of the extended coiled coils and/or the helix-turn domains.
We can focus on the peptide inhibition data for the SV5
viral fusion system since no peptide inhibition data has been
published for HA and the data for SV5 are more detailed
than other studies. Joshi et al. (1998) found that peptides of
the N-terminal heptad repeat region could block aqueous
contents mixing between CV-1 cells expressing the SV5 F
protein and erythrocytes, but not lipid mixing, whereas
peptides of the C-terminal heptad repeat region could block
aqueous contents and lipid mixing between the cells. Their
explanation was that the C-terminal peptides bind to the
N-terminal heptad repeat domain of the protein in order to
block the first step of fusion, i.e., lipid mixing, and the
N-terminal peptides bind to the C-terminal heptad repeat
domain of the protein, in order to block the second step of
fusion, i.e., contents mixing. This explanation is contrary to
the common assumption that the C-terminus peptides bind
to the C-terminus heptad repeat binding site and the N-
terminal peptides bind to the N-terminus heptad repeat
domain.
The model proposed here yields a more natural explana-
tion assuming, of course, that native SV5 F has the same
general orientation and behavior as HA. The C-terminal
peptides should block the “helix-turn” element of the fusion
mechanism proposed here. How does this block lipid and
content mixing, since it wouldn’t block the formation of the
extended coiled coil? Recall that the formation of the ex-
tended coiled coil is only the first (and high-energy) tran-
sition and it only creates the first defect. If the subsequent
steps, like the helix turn, are inhibited, then the nascent
fusion site will simply dissipate, as lipids eventually flow
into it. This would certainly block contents mixing and the
lipid mixing between the apposed membranes.
However, the N-terminal peptides should block the “ex-
tended coiled coil” formation of this fusion mechanism
which, at first glance, would be expected to block all inter-
actions between the membranes, even with the model pro-
posed by Joshi et al. (1998) and Baker et al. (1999). How-
ever, the formation of the extended coiled coil may not be
easy to stop because it involves so much free energy. Qiao
et al. (1998) found that to abolish fusion of HA expressing
cells required two prolines to be expressed appropriately
within the coiled coil sequence to inhibit fusion. Further-
more, the N-terminal portion of the protein should not be
accessible for very long for binding by the N-terminal
peptides, since the extended coiled coil formation is coop-
erative and it occurs within a protein aggregate. Once
formed, the extended coiled coil has done much of its job,
even if excess peptide could pry it apart. These competing
effects would reduce binding of the N-terminal peptide and,
therefore, the number of proteins capable of forming ex-
tended coiled coils would be reduced, but not necessarily
eliminated. Chernomordik et al. (1998) have shown that
reducing the cell surface density of HAs stops contents
mixing, while lipid mixing continues via hemifusion. This
explanation is speculative, but it is a natural consequence of
the fusion model proposed here and it maintains the ex-
pected topology of N- and C-terminal peptide binding to the
appropriate heptad repeat domains of the fusion protein.
With HIV, Munoz-Barroso et al. (1998) found that the
C-terminal peptide of the fusion protein Env would block
contents mixing, but not lipid mixing. While reverse to the
SV5 F system, this result may suggest that the “helix-turn”
transitions can be partially blocked adequately to stop con-
tents mixing, but not some lipid mixing. Eckert et al. (1999)
constructed D-peptides complementary to the highly con-
served helix-turn binding pocket of env’s C-terminus which
blocked infection and syncitia formation, in accord with the
mechanism proposed here.
However, Env may look and act differently from HA. For
example, data suggest that the HA molecules involved in
cell surface attachment via HA1-sialic acid binding are not
involved in fusion or are very slow (Ellens et al., 1990;
Bentz, 1992; Alford et al., 1994). Millar et al. (1999) found
that HAs bound to Fab linked to target membrane can
eventually mediate fusion. The primary route of HIV infec-
tion usually starts with binding of Env to CD4, but it is the
subsequent binding of Env to a chemokine receptor protein
that is required for fusion (Feng et al., 1996; Doms and
Peiper, 1998; Xiao et al., 1999). In fact, there is an Env
mutant that binds directly to either chemokine receptor,
CXCR4 and CRC5, and mediates fusion (Hoffman et al.,
1999).
These chemokine receptors have seven transmembrane
domains. While the type of chemokine receptor bound by
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Env is important for the progression of HIV infection from
macrophages to T-cells (Doms and Peiper, 1998; Xiao et al.,
1999), it is clear how the recruitment of proteins with seven
transmembrane domains into the collar of proteins at the
fusion site could facilitate aggregation of Env, possibly by
the mechanism proposed by Kozlov and Chernomordik
(1998). Fusion could then proceed as depicted for HA. Even
more intriguing is the possibility that these chemokine re-
ceptors themselves create a site of restricted lipid flow in the
target membrane. If the “fusion peptide” of Env embedded
initially in the target membrane at a site of lipid flow
restriction, due to preliminary conformational changes, then
extraction by the formation of an extended coiled coil would
initiate destabilization from the target, rather than the viral
bilayer. Analysis of this fusion system can determine the
stoichiometry of the proteins at the fusion site (Bentz,
2000), which will be essential to sorting out how the fusion
actually occurs.
Finally, we can consider eukaryotic fusion. While eu-
karyotic fusion may entail many elements (Mayer, 1999),
the “minimal” v-SNARE/t-SNARE cognates proposed by
Rothman and co-workers (So¨llner et al., 1993; Weber et al.,
1998; McNew et al., 1999) shows a coiled coil core struc-
ture similar to that of the viruses (Skehel and Wiley, 1998;
Baker et al., 1999). However, no “fusion peptide” (amphi-
pathic -helix or otherwise) has yet been proven, which is
an essential element of the model proposed here. Neverthe-
less, it is possible that the v-snares do contain a “fusion
peptide.” Jahn and Su¨dhof (1994) Fig. 3 shows a helical
wheel representation of the fusion peptide of HA and of an
18-amino acid sequence of synaptobrevin 2, syb2, which is
the v-snare protein associated with the t-snares syntaxin and
SNAP 25 (Weber et al., 1998), whose core coiled coil
complex has been recently solved (Sutton et al., 1998). The
black band highlights the hydrophobic face of both peptides
and it is clear that syb2 shows a “fusion peptide” profile.
This stretch (amino acids 38–55) occupy the center of the
syb2 coiled coil domain in the crystallized 7S core complex,
just N-terminal to the central arginine (R56) of the 7S
complex (Sutton et al., 1998).
Before the docking of the v-snare syb-2 with the t-snare
complex, syb2 is relatively unstructured (Fasshauer et al.,
1997; Go¨tte and Fischer von Mollard, 1998). Thus, it could
be that this stretch of amino acids plays two roles in its life
cycle, depicted in Fig. 4: 1) as a “fusion peptide” embedded
in the secretory vesicle’s outer membrane until docking
with the target membrane; and 2) as a piece of the new
four-stranded coiled coil formed by syb2, syntaxin, and the
N- and C-termini of SNAP25 after docking. The formation
of the new coiled coil would pull syb2 out of the vesicle
membrane and, if vesicular membrane proteins restrict lipid
flow, then this eukaryotic fusion system could work the
same way as HA. The other v-snare cognates (Weimbs et
al., 1998) show similar “fusion peptide” profiles on the
helical wheel for the aligned 18-amino acid sequences N-
terminal to the central arginines, while the t-snare cognates
do not (data not shown). McNew et al. (1999) found that
adding peptide linkers between the transmembrane domain
and the core complex coiled coil domain for either the
v-snare VAMP-2 (aka syb-2) or the t-snare member syn-
taxin 1A decreased fusion in their reconstituted system.
While there are several explanations for this result, the
model proposed here would predict this result also. The
linkers would allow the apposed membranes to be further
apart after the formation of the new coiled coil, thereby
making it more difficult for the target bilayer lipids to reach
the hydrophobic defect. Finally, while neurosynaptic secre-
tion is nonleaky and this fusion mechanism is to some
extent leaky, there is no essential contradiction. The reso-
lution could be that there are other proteins attached periph-
FIGURE 3 The possible “fusion peptide” of the v-snares. Helical wheel representation of the N-terminus of HA2, showing the hydrophobic face of the
fusion peptide with the black band, and residues 38–55 of synaptobrevin 2, which is the v-snare cognate for the t-snares syntaxin and SNAP25 (Weber
et al., 1998). Syb2 could have a “fusion peptide” by this criteria, which would allow this eukaryotic fusion system to function according to the same model
as proposed for HA. These residues form the center stretch of the coiled coil core complex of syb2/syntaxin/SNAP25, just N-terminal of the central arginine,
R56 (Sutton et al., 1998), which would form after vesicle docking to the target membrane. Other v-snares show similar hydrophobic faces on helical wheel
representations, e.g., regions 35–52 of snc1, 172–189 of Nyv1, and to a lesser extent regions 137–154 of sar1 and 138–155 of sec22.
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erally to the fusion site whose job is to contain the leakage
(Bentz et al., 1990).
I thank Dr. Harma Ellens for a critical reading of the manuscript.
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